Can Amantadine Be Given Once Daily?
Yes, amantadine can be administered once daily, but this is only appropriate for specific populations and formulations—standard immediate-release amantadine requires twice-daily dosing for most patients, while extended-release formulations are specifically designed for once-daily administration.
Standard Immediate-Release Formulation Dosing
Adults Under 65 Years
- Standard dosing is 100 mg twice daily (200 mg total daily dose) for both influenza prophylaxis/treatment and Parkinson's disease 1, 2
- The FDA label explicitly states that while 200 mg can be given as a single daily dose, if CNS side effects develop with once-daily dosing, a split dosage schedule (twice daily) may reduce such complaints 2
- Once-daily dosing at 200 mg has not been demonstrated to be as effective as the standard twice-daily regimen for all indications 2
Adults 65 Years and Older
- The total daily dose should be reduced to 100 mg per day due to age-related decline in renal function 1, 3, 4, 2
- This 100 mg can be given as a single daily dose in elderly patients 2
- The lower dose minimizes CNS side effects while maintaining efficacy 3
Pediatric Patients
- Children require twice-daily dosing 1, 2
- Ages 1-9 years: 5 mg/kg/day divided into two doses (maximum 150 mg/day) 1, 2
- Ages 10-12 years: 100 mg twice daily 1, 2
Extended-Release Formulations
ADS-5102 (Bedtime Dosing)
- ADS-5102 is specifically designed for once-daily administration at bedtime 5, 6
- This formulation provides high amantadine concentrations upon waking and throughout the day, with lower concentrations in the evening 5
- Peak concentration occurs 12-16 hours post-dose, resulting in mid-day peak levels when dyskinesia symptoms are most problematic 5
- Effective doses range from 260-340 mg once daily at bedtime for levodopa-induced dyskinesia 6
OS320 (Morning Dosing)
- OS320 extended-release tablets allow once-daily morning administration 7
- Peak amantadine concentration occurs approximately 7.5 hours post-dose 7
- At steady state, once-daily extended-release dosing is bioequivalent to twice-daily immediate-release dosing at the same total daily dose 7
Renal Impairment Adjustments
Dose reduction is mandatory for renal dysfunction, which may result in effective once-daily dosing:
- Creatinine clearance 30-50 mL/min/1.73m²: 200 mg on day 1, then 100 mg once daily 2
- Creatinine clearance 15-29 mL/min/1.73m²: 200 mg on day 1, then 100 mg every other day 2
- Creatinine clearance <15 mL/min/1.73m²: 200 mg every 7 days 2
- Hemodialysis patients: 200 mg every 7 days 2
Clinical Considerations
When Once-Daily Dosing May Be Appropriate
- Elderly patients (≥65 years) receiving the reduced 100 mg daily dose 1, 2
- Patients with renal impairment requiring dose reduction 2
- Patients using extended-release formulations specifically designed for once-daily administration 5, 7, 6
- Patients experiencing intolerance to 200 mg daily who require dose reduction to 100 mg 2
Important Caveats
- The 100 mg once-daily dose has not been studied for treatment of acute influenza illness and may not be as effective as 200 mg daily for prophylaxis 2
- If sleep disturbances occur with twice-daily dosing, avoid taking the second dose too close to bedtime rather than switching to once-daily dosing 3
- Standard immediate-release formulations given once daily at 200 mg may cause more CNS side effects than split dosing 2
- Extended-release and immediate-release formulations are not bioequivalent and cannot be substituted on a mg-per-mg basis 5